Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2024 | Story Jacky Tshokwe | Photo Supplied
Dr Rosaline Sebolao
Dr Rosaline Sebolao, Teaching and Learning Manager in the Faculty of The Humanities at the University of the Free State, has been recognised with an award from Higher Education Resource Services South Africa (HERS-SA).

The University of the Free State (UFS) is proud to announce that Dr Rosaline Sebolao, our Teaching and Learning Manager in the Faculty of The Humanities, has been recognised with an award from Higher Education Resource Services South Africa (HERS-SA). At the ceremony, Dr Sebolao was one of the top five finalists for her exceptional contributions to higher education, particularly in academic administration.

The HERS-SA Award celebrates outstanding women in academic administration, acknowledging their crucial role in supporting and transforming the higher education landscape. According to Dr Sebolao, “The significance of this award lies in its developmental and transformative impact.” She explains that it highlights the essential contributions made by women in academic administration and encourages gender transformation within universities. This recognition empowers women to take on leadership roles, shifting the focus beyond traditional academic achievements.

Award recipients are selected based on a minimum of five years of demonstrated leadership in academic administration. Dr Sebolao’s innovative leadership practices, her contributions to institutional performance, her peer mentoring, and community engagement were all key criteria in her selection. Her mentoring efforts, particularly through school visits and support for underprivileged students, have made a lasting impact on the community and her peers.

Reflecting on the honour of receiving the award, Dr Sebolao describes it as “humbling and exciting”. She felt especially inspired as a mentor, noting that this recognition has the potential to encourage young women and men to strive for excellence in their academic and administrative pursuits.

Achievements leading to the award

In her role as Teaching and Learning Manager, Dr Sebolao has made significant contributions to both students and academics at the UFS. She has initiated several impactful projects, including the establishment of student indabas and entrepreneurial initiatives aimed at addressing graduate unemployment. Her commitment to improving communication led to the launch of a faculty newsletter, enhancing engagement among academics.

Among her most notable achievements is the Scholarship of Teaching and Learning (SoTL) project, which culminated in the UFS’ inaugural SoTL seminar in July 2024. She also spearheaded the Humanities Excellence Awards, encouraging faculty to pursue greater academic and research recognition. Her dedication to engaged scholarship extended beyond the university, resulting in community collaborations such as the establishment of a school library in Ikgomotseng, promoting literacy and education among local learners.

Dr Sebolao’s academic journey began after transitioning from the business sector to academia in 2013. Her experience in roles such as Peer Mentorship Coordinator and Teaching and Learning Coordinator at the Central University of Technology, and later as Manager of Special Projects in Teaching and Learning, helped shape her leadership style. She joined the UFS during the challenging COVID-19 period, a time that also marked some of her greatest achievements.

One of the key challenges that Dr Sebolao faced was overcoming the isolated nature of work within the faculty. By fostering a collaborative culture, she succeeded in promoting teamwork and innovation across departments. This approach not only improved institutional collaboration, but also strengthened her professional impact.

Dr Sebolao’s relationship with HERS-SA has been instrumental in her development as a leader in higher education. Since participating in the HERS-SA Academy in 2018, she has connected with influential women in the sector and solidified her commitment to mentoring others. Winning this award affirms the importance of mentoring and paves the way for future leaders in higher education.

Looking to the future, Dr Sebolao aspires to continue championing gender transformation in leadership. She aims to empower more women, particularly black women, to take on leadership roles within academia. Her focus is on fostering community development through collaborative projects that promote sustainable living, aligning with her broader vision for teaching and learning at the UFS.

Dr Sebolao encourages young women to believe in their abilities and seek mentorship for guidance and support. She emphasises that perseverance, coupled with a strong support network, is essential to achieving leadership success in higher education.

Outside of her professional life, Dr Sebolao draws motivation from her family and community work. Guided by Ecclesiastes 9:10, which emphasises dedication in all endeavours, and inspired by Mahatma Gandhi’s words, “Be the change you want to see in the world,” she remains committed to leading with passion and integrity.

The UFS community is incredibly proud of Dr Sebolao’s achievement and her continuous contributions to academic excellence and gender transformation in higher education. This award is a testament to her tireless efforts and dedication to empowering others.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept